GoKawiilRoughly one in twenty adults in the United States lives with generalized anxiety disorder (GAD). For those with severe symptoms, daily life can become overwhelming. Many avoid leaving home, struggle to maintain employment, and find it difficult to build meaningful social connections. Unfortunately, traditional medications often provide little relief.
At the University of California, San Francisco (UCSF), neuroscientist Jennifer Mitchell, PhD, is leading research into innovative treatments for conditions such as anxiety, depression, PTSD, impulsivity, stress, and addiction. She believes a new approach could help where standard therapies fall short -- and early results are encouraging.
This potential breakthrough treatment? A carefully developed pharmaceutical form of LSD.
What is generalized anxiety disorder?
Generalized anxiety disorder is a persistent and excessive form of anxiety that feels out of proportion to actual events or situations. It interferes with daily functioning, affecting relationships, work, and overall quality of life.
People living with GAD may struggle to focus, make decisions, or remember information, making it difficult to manage responsibilities at work or home. The condition can also lead to fatigue, irritability, and secondary depression. Many individuals hesitate to leave their homes for fear of feeling trapped, embarrassed, or helpless in social or public settings.
How is it different from day-to-day anxiety?
A hallmark of generalized anxiety disorder is that it manifests as physical symptoms. Persistent worry activates the body's fight-or-flight response, triggering stress hormones that cause physical effects. Patients may have muscle tension and rapid breathing, and report symptoms like headaches and insomnia, ringing in the ears, and cardiovascular, respiratory, and gastrointestinal issues.
How is generalized anxiety disorder treated?
It's usually treated with medications like Zoloft and Paxil that boost and stabilize the neurotransmitter serotonin, leading to reduced anxiety and enhanced emotional well-being. These medications have been found to reduce symptoms by an average of 1.25 points on the 56-point anxiety scale -- insufficient to make significant difference for at least some patients.
... continue reading